Does Dr. COLLEEN COTTON have financial conflicts of interest?

Dr. COLLEEN COTTON (M.D.) has received a total of $15,789 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $15,789 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. COLLEEN COTTON?

According to CMS Open Payments data, Dr. COLLEEN COTTON received funding from PIERRE FABRE PHARMACEUTICALS ($7,664), NOVARTIS PHARMACEUTICALS CORPORATION ($3,284), and LEO PHARMA ($2,900).

Does Dr. COLLEEN COTTON receive research grants or speaking fees?

Dr. COLLEEN COTTON has received $15,789 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. COLLEEN COTTON

M.D.Real-Time Hydrated

Specialty: Dermatology, Pediatric Dermatology

Practice Location: WASHINGTON, DC 20010

NPI Number: 1669818589

LIFETIME INDUSTRY VALUE

$15,789

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. COTTON is a verified Dermatology, Pediatric Dermatology practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. COTTON had an overall industry promotional and research financial footprint of $15,789 as recorded in the federal CMS Open Payments database.

$15,789 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. COTTON's primary funding source is PIERRE FABRE PHARMACEUTICALS, which accounts for $7,664 (representing 48.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PIERRE FABRE PHARMACEUTICALS

Rank 1

$7,664

48.5%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$3,284

20.8%

LEO PHARMA

Rank 3

$2,900

18.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.